One study by Spranger et al[132] reported that tumor-intrinsic β-catenin activation by downregulation of CCL4 expression might inhibit the recruitment of CD103+ dendritic cells and infiltration of T cells into the tumor microenvironment. The gene discussed is CCL4; the disease is neoplasm.